AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 24330810
Drug: Sham acupuncture
RxNorm normalized name: BLACK BEAN ANTI HAIR LOSS SHAM POO SET KIT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sham acupuncture treatment for chronic dizziness
Trial: 21670727
Drug: Transdermal estradiol
RxNorm normalized name: estradiol Transdermal System
DrugBank: Estradiol (DB00783)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Transdermal estradiol + dydrogesteron (37.5 µg/24h)
Trial: 21670727
Drug: Transdermal estradiol
RxNorm normalized name: estradiol Transdermal System
DrugBank: Estradiol (DB00783)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Transdermal estradiol + medroxyprogesteron (50 µg/24h)
Trial: 21670727
Drug: Oral estradiol
RxNorm normalized name: estradiol Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral estradiol + noretisteron (1mg)
Trial: 19424460
Drug: Health extension
RxNorm normalized name: Healthy Mama
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Health extension workers (HEWs) trained to identify TB suspects, collect sputum, and provide directly observed treatment in intervention kebeles.
Trial: 16771791
Drug: Bicalutamide 300
RxNorm normalized name: Bicalutamide
DrugBank: Bicalutamide (DB01128)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Bicalutamide 300 mg
Trial: 16771791
Drug: Bicalutamide 450
RxNorm normalized name: Bicalutamide
DrugBank: Bicalutamide (DB01128)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Bicalutamide 450 mg
Trial: 16771791
Drug: Bicalutamide 600
RxNorm normalized name: Bicalutamide
DrugBank: Bicalutamide (DB01128)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Bicalutamide 600 mg
Trial: 15024300
Drug: Rosuvastatin (5,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rosuvastatin (5, 10, 20, 40, or 80 mg)
Trial: 15024300
Drug: Rosuvastatin (5-80
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rosuvastatin (5-80 mg)
Trial: 15024300
Drug: Rosuvastatin (doses
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rosuvastatin (doses > 5 mg)
Trial: 11122839
Drug: Short-course chemotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Short-course chemotherapy regimens with radiotherapy
Trial: 11122839
Drug: Short-course chemotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Short-course chemotherapy regimens without radiotherapy
Trial: 9262937
Drug: Standard medication
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard medication clinic approach
Trial: 7967433
Drug: COALL therapy-protocol
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: COALL therapy-protocol
Trial: 16431378
Drug: Diclofenac sodium
RxNorm normalized name: Diclofenac Sodium
DrugBank: Diclofenac (DB00586)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Diclofenac sodium 50 mg tablets (fasted state)
Trial: 16431378
Drug: Diclofenac sodium
RxNorm normalized name: Diclofenac Sodium
DrugBank: Diclofenac (DB00586)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Diclofenac sodium 50 mg tablets (fed state)
Trial: 16431378
Drug: Diclofenac sodium
RxNorm normalized name: Diclofenac Sodium
DrugBank: Diclofenac (DB00586)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Diclofenac sodium 50 mg tablets
Trial: 12860856
Drug: Pyridostigmine 30
RxNorm normalized name: Pyridostigmine 30 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pyridostigmine 30 mg
Trial: 8872133
Drug: Cholesterol-lowering drug
RxNorm normalized name: Cholesterol
DrugBank: Cholesterol (DB04540)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cholesterol-lowering drug (simvastatin)
Trial: 8872133
Drug: Subjects with
RxNorm normalized name: Ex vivo, lentiviral vector (LV)-mediated, genetically modified autologous cell therapy intended for the stable provision of functional human iduronate-2-sulfatase (IDS) enzyme to subjects with Hunter syndrome
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Subjects with TC > 249 mg/dl
Trial: 6638413
Drug: Rush treatment
RxNorm normalized name: Canesten Clotrimazole Thrush Treatment 3 Day
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rush treatment schedule
Trial: 6638413
Drug: Conventional treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional treatment schedule
Trial: 6638413
Drug: HBV treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: HBV treatment
Trial: 6638413
Drug: YJV treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: YJV treatment
Trial: 24886683
Drug: Interpersonal problem-solving
RxNorm normalized name: Solv X
DrugBank: Salicylic acid (DB00936)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Interpersonal problem-solving therapy plus treatment-as-usual
Trial: 24886683
Drug: Treatment-as-usual alone
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Treatment-as-usual alone
Trial: 22784777
Drug: Tanezumab (2.5,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tanezumab (2.5, 5, or 10 mg)
Trial: 18855928
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of 16-item identification test and detection threshold task
Trial: 11409308
Drug: Endoscopic treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Endoscopic treatment (ventriculoscopic operation)
Trial: 7935654
Drug: Zidovudine regimen
RxNorm normalized name: Zidovudine
DrugBank: Zidovudine (DB00495)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Zidovudine regimen (100 mg orally five times daily antepartum, 2 mg/kg intravenously during labor, 1 mg/kg/hour until delivery, and 2 mg/kg orally every six hours for six weeks for newborns)
Trial: 3067924
Drug: Flurbiprofen 300
RxNorm normalized name: Flurbiprofen
DrugBank: Flurbiprofen (DB00712)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Flurbiprofen 300 mg per day
Trial: 3067924
Drug: Flurbiprofen b.i.d.
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Flurbiprofen b.i.d. (twice daily)
Trial: 3067924
Drug: Flurbiprofen t.i.d.
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Flurbiprofen t.i.d. (thrice daily)
Trial: 22500659
Drug: Physical therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Physical therapy exercises (control group)
Trial: 18269639
Drug: Metformin (M
RxNorm normalized name: Product containing metformin (medicinal product)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metformin (M group)
Trial: 18269639
Drug: Glyburide (G
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Glyburide (G group)
Trial: 12942563
Drug: Zoledronic acid
RxNorm normalized name: Zoledronic Acid
DrugBank: Zoledronic acid (DB00399)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Zoledronic acid (4 mg as a 15-minute infusion)
Trial: 10632128
Drug: G-suit inflation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: G-suit inflation with LBNP (50 mm Hg)
Trial: 10632128
Drug: Control (baseline
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control (baseline without G-suit and LBNP)
Trial: 8867251
Drug: 100 mg
RxNorm normalized name: urea 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100 mg Ro 15‐8081 (divided into 2 doses)
Trial: 8867251
Drug: Piroxicam (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Piroxicam (20 mg/day, piroxicam in the morning and placebo in the evening)
Trial: 28832393
Drug: Caffeine (5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Caffeine (5 mg·kg body mass)
Trial: 27605955
Drug: Prophylactic phenylephrine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prophylactic phenylephrine weight adjusted dose infusion at 0.5 micrograms per kilogram per minute
Trial: 27605955
Drug: Prophylactic phenylephrine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prophylactic phenylephrine fixed dose infusion at 37.5 micrograms per minute
Trial: 17414226
Drug: Duloxetine 200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Duloxetine 200 mg twice daily
Trial: 10759934
Drug: Pericranial injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pericranial injection of 10 x 20 mouse units botulinum toxin A
Trial: 1993808
Drug: Budesonide (reduced
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Budesonide (reduced dose)
Trial: 1993808
Drug: Budesonide (maintained
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Budesonide (maintained dose)
Trial: 29359339
Drug: Subcrestal implants
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Subcrestal implants (adapted to soft tissue thickness)
Trial: 29359339
Drug: Equicrestal implants
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Equicrestal implants (control)
Trial: 28893309
Drug: Controlled-release oxycodone/naloxone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Controlled-release oxycodone/naloxone (OXN-CR)
Trial: 28893309
Drug: Controlled-release oxycodone
RxNorm normalized name: oxycodone
DrugBank: Oxycodone (DB00497)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Controlled-release oxycodone (OX-CR)
Trial: 25339501
Drug: Intradiscal biacuplasty
RxNorm normalized name: Valrubicin Intravesical Solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intradiscal biacuplasty (IDB) treatment
Trial: 25339501
Drug: Cross-over from
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cross-over from sham to IDB treatment
Trial: 18208600
Drug: Active test
RxNorm normalized name: Accu-Chek Active Test Strip
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Active test product (Hyal-Joint) 80 mg/day
Trial: 1580284
Drug: Perindopril 2
RxNorm normalized name: perindopril 2 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Perindopril 2 mg once daily
Trial: 1580284
Drug: Atenolol 25
RxNorm normalized name: atenolol 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atenolol 25 mg once daily
Trial: 30920122
Drug: Sorafenib 600
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sorafenib 600 mg/day
Trial: 30920122
Drug: Sorafenib 400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sorafenib 400 mg/day
Trial: 30920122
Drug: Simulated dose-reduction
RxNorm normalized name: bisacodyl
DrugBank: Bisacodyl (DB09020)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Simulated dose-reduction strategy of Sorafenib 800 mg/day for initial two cycles followed by dose reductions
Trial: 29340321
Drug: Abatacept (modified
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Abatacept (modified CTLA4‐Ig) administered for 4 months
Trial: 24127838
Drug: Penile vibratory
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Penile vibratory stimulation (PVS) device (FERTI CARE(®) vibrator), used daily for at least 1 week before surgery and for 6 weeks after catheter removal.
Trial: 20202536
Drug: 1.0 g
RxNorm normalized name: IODINE 11.0 g in 1 L TOPICAL SOLUTION [T.D.]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1.0 g oral acetaminophen
Trial: 9796070
Drug: Ultra-high dosage
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ultra-high dosage streptokinase (1.5 million U/h for 6h daily, n = 77)
Trial: 9796070
Drug: Conventional dosage
RxNorm normalized name: osage orange pollen extract
DrugBank: Maclura pomifera pollen (DB10988)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional dosage streptokinase (100,000 U/h, n = 79)
Trial: 9796070
Drug: Ultra-high dosage
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ultra-high dosage streptokinase (group A)
Trial: 9796070
Drug: Conventional dosage
RxNorm normalized name: osage orange pollen extract
DrugBank: Maclura pomifera pollen (DB10988)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional dosage streptokinase (group B)
Trial: 8582783
Drug: Zinc sulphate
RxNorm normalized name: Zinc sulphate
DrugBank: Zinc acetate (DB14487)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Zinc sulphate 200 mg orally for 30 days
Trial: 17427
Drug: Fazadinium 0.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fazadinium 0.5 mg/kg
Trial: 29070055
Drug: Open excision
RxNorm normalized name: BOTTLE OPENER
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Open excision after arthroscopic treatment (Group B)
Trial: 19632965
Drug: Constraint-Induced Movement
RxNorm normalized name: constant albicans extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Constraint-Induced Movement Therapy (CIMT) for 6 hours a day during waking hours for 4 weeks
Trial: 19632965
Drug: Traditional therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Traditional therapy only (Control)
Trial: 17489733
Drug: Molecular markers
RxNorm normalized name: Molecular AF
DrugBank: Tolnaftate (DB00525)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Molecular markers (e.g., ERCC1)
Trial: 12201933
Drug: alpha-1 adrenoceptor
RxNorm normalized name: alpha 1-antitrypsin
DrugBank: Alpha-1-proteinase inhibitor (DB00058)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: alpha-1 adrenoceptor antagonists (alpha-1ARA)
Trial: 9659537
Drug: Theophylline (oral
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Theophylline (oral dose titrated twice daily)
Trial: 25159300
Drug: 20 mg
RxNorm normalized name: urea 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 mg of teneligliptin every day (Group A)
Trial: 25159300
Drug: 20 mg
RxNorm normalized name: urea 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 mg of teneligliptin every other day (Group B)
Trial: 23017585
Drug: Lactobacillus plantarum
RxNorm normalized name: Lactobacillus Plantarum
DrugBank: Lactobacillus plantarum (DB11360)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lactobacillus plantarum (CECT 7527, CECT 7528 and CECT 7529) - 1 capsule daily containing 1·2 × 10(9) colony-forming units for 12 weeks
Trial: 23017585
Drug: Lactobacillus plantarum
RxNorm normalized name: Lactobacillus Plantarum
DrugBank: Lactobacillus plantarum (DB11360)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lactobacillus plantarum (CECT 7527, CECT 7528 and CECT 7529) - 1 capsule daily for 12 weeks
Trial: 19500037
Drug: Higher levels
RxNorm normalized name: peanut allergenic extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Higher levels of opsonizing antibodies to CS2 IEs
Trial: 16371604
Drug: iv iron
FDA approved: no
EMA approved: no
PMDA approved: no
Description: iv iron alone (200 mg of iron sucrose on POD 1, 2, and 3)
Trial: 16371604
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of iv iron and EPO (600 U x kg(‐1) on POD 1 and 3)
Trial: 7753750
Drug: Long-term medical
RxNorm normalized name: benzethonium
DrugBank: Benzethonium (DB11125)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Long-term medical therapy
Trial: 2225558
Drug: Calcium infusion
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Calcium infusion at 15 ml/hour using 10% CaCl2
Trial: 2225558
Drug: Calcium infusion
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Calcium infusion at 20 ml/hour using 10% CaCl2
Trial: 2225558
Drug: Calcium infusion
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Calcium infusion at 10 ml/hour using 10% CaCl2
Trial: 2225558
Drug: Dialyzate with
RxNorm normalized name: Dialyvite 800 with Zinc Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dialyzate with 1.5 mmol/l calcium
Trial: 2225558
Drug: Dialyzate with
RxNorm normalized name: Dialyvite 800 with Zinc Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dialyzate with 1.75 mmol/l calcium
Trial: 2225558
Drug: Dialyzate calcium-free
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dialyzate calcium-free with varying calcium infusion rates
Trial: 487912
Drug: Cimetidine (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cimetidine (1 g per day for 4 weeks)
Trial: 487912
Drug: Antacid (210
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antacid (210 ml/day for 4 weeks)
Trial: 31375051
Drug: Dasotraline 4
RxNorm normalized name: Dasotraline
DrugBank: Dasotraline (DB12305)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dasotraline 4 mg
Trial: 25762165
Drug: Duloxetine 20
RxNorm normalized name: duloxetine 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Duloxetine 20 mg/day for 1 week, then 40 mg/day for 3 weeks
Trial: 25762165
Drug: Vitamin B12
RxNorm normalized name: Vitamin B12
DrugBank: Cyanocobalamin Co-57 (DB09385)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vitamin B12 (VB12) 1.5 mg/day for 4 weeks
Trial: 21469249
Drug: Medicamental therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Medicamental therapy (Control)
Trial: 16309929
Drug: Therapeutic education
RxNorm normalized name: Moisturel Therapeutic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Therapeutic education and functional readaptation (TEFR) added to conventional (pharmacological) treatment (n=51)
Trial: 16309929
Drug: Conventional (pharmacological)
RxNorm normalized name: COPD pharmacologic substance
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional (pharmacological) treatment only (n=49)
Trial: 11301848
Drug: Gemcitabine and
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gemcitabine and cisplatin as induction therapy followed by concomitant chemoradiation
Trial: 11301848
Drug: Cisplatin-based combinations
RxNorm normalized name: Cisplatin
DrugBank: Cisplatin (DB00515)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Cisplatin-based combinations (with gemcitabine, paclitaxel, or vinorelbine) as induction therapy
Trial: 8424584
Drug: Low-dose polyunsaturated
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose polyunsaturated fatty acids from fish oil (350 mg daily) in microencapsulated form
Trial: 8424584
Drug: Low-dose polyunsaturated
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose polyunsaturated fatty acids from fish oil (350 mg daily) in gelatine capsules
Trial: 8424584
Drug: Both formulations
RxNorm normalized name: Bothrops atrox venom
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Both formulations of fish oil
Trial: 27444039
Drug: Atomoxetine oral
RxNorm normalized name: atomoxetine Oral Capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atomoxetine oral solution 50 mg
Trial: 27444039
Drug: Atomoxetine capsules
RxNorm normalized name: Atomoxetine Capsules
DrugBank: Atomoxetine (DB00289)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Atomoxetine capsules 50 mg
Trial: 27444039
Drug: Atomoxetine oral
RxNorm normalized name: atomoxetine Oral Capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atomoxetine oral solution
Trial: 16150136
Drug: phe-free protein
RxNorm normalized name: protein C
DrugBank: Protein C (DB11312)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: phe-free protein substitute supplemented with EFA (test-treatment group)
Trial: 10388983
Drug: Macroalbuminuric subjects
RxNorm normalized name: Ex vivo, lentiviral vector (LV)-mediated, genetically modified autologous cell therapy intended for the stable provision of functional human iduronate-2-sulfatase (IDS) enzyme to subjects with Hunter syndrome
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Macroalbuminuric subjects (AER = 300 mg/day)
Trial: 8637536
Drug: Co-trimoxazole (800
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Co-trimoxazole (800 mg of sulfamethoxazole and 160 mg of trimethoprim) given twice daily for 24 months
Trial: 6472539
Drug: L-carnitine (3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: L-carnitine (3 g/day)
Trial: 31829921
Drug: 5% Date
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5% Date Palm Kernel Extract (DPKE) cream applied twice daily for 8 weeks
Trial: 18187428
Drug: PGA (60
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PGA (60 mg)
Trial: 15890731
Drug: GnRH antagonist
RxNorm normalized name: GnRH
DrugBank: Gonadorelin (DB00644)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: GnRH antagonist (cetrorelix 0.25 mg daily starting when the leading follicle reached 14 mm)
Trial: 12626212
Drug: Hormone replacement
RxNorm normalized name: Parathyroid Hormone
DrugBank: Parathyroid hormone (DB05829)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Hormone replacement therapy (HRT) using a combination of transdermal estradiol gel and a progestin other than MPA
Trial: 8208872
Drug: Galanthamine 10
RxNorm normalized name: Galanthamine
DrugBank: Galantamine (DB00674)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Galanthamine 10 mg
Trial: 8208872
Drug: Galanthamine 15
RxNorm normalized name: Galanthamine
DrugBank: Galantamine (DB00674)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Galanthamine 15 mg
Trial: 2563217
Drug: Oral potassium
RxNorm normalized name: Oral Film
DrugBank: Sodium citrate (DB09154)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral potassium pretreatment
Trial: 1164890
Drug: Sisomicin (1.0
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sisomicin (1.0 mg/kg body-weight, 2-3 times daily)
Trial: 1164890
Drug: Gentamicin (1.0
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gentamicin (1.0 mg/kg body-weight, 1-hour infusion)
Trial: 1164890
Drug: Sisomicin (1.0
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sisomicin (1.0 mg/kg body-weight, 1-hour infusion)
Trial: 1164890
Drug: Tobramycin (1.0
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tobramycin (1.0 mg/kg body-weight, 1-hour infusion)
Trial: 30616534
Drug: Axitinib titration
RxNorm normalized name: Axitinib
DrugBank: Axitinib (DB06626)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Axitinib titration (5 mg bid)
Trial: 23651793
Drug: 1 ×
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 × 30 mg/mL subcutaneous injection
Trial: 23651793
Drug: 2 ×
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2 × 15 mg/mL subcutaneous injections
Trial: 21060995
Drug: BZP/TFMPP (100/30
FDA approved: no
EMA approved: no
PMDA approved: no
Description: BZP/TFMPP (100/30 mg)
Trial: 17308499
Drug: 80 mg
RxNorm normalized name: RNA 180 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 80 mg soy-derived isoflavones
Trial: 15183623
Drug: Compression treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Compression treatment with superficial venous surgery